Scripps 38th Annual New Treatments in Chronic Liver Disease 2024

Scripps 38th Annual New Treatments in Chronic Liver Disease 2024

Regular price
$40.00
Sale price
$40.00
Regular price
Sold out
Unit price
per 

Scripps 38th Annual New Treatments in Chronic Liver Disease 2024

Format: 16 videos + 1 pdf, size: 2.23 GB

Course Audience: hepatologists, gastroenterologists, infectious disease physician

Overview:

Course Overview

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives

After attending this live activity, participants should be able to:

• Assess new therapies for curing Delta Hepatitis and Hepatitis B.

• Review guidelines for the management of cholestatic liver diseases.

• Outline recent advances in the understanding and management of ascites and hepatorenal syndrome.

• Evaluate drugs in development for metabolic liver disease.

• Address causes and trends of liver disease and liver transplantation in women.

Target Audience

• Hepatologists

• Gastroenterologists

• Infectious Disease Specialists

 

brochure_for_web_liver24 (PDF Format)

ESLD, HCC AND TRANSPLANTATION Advances in the Treatment of HCC (Video MP4 Format)

ESLD, HCC AND TRANSPLANTATION Chronic Liver Disease and Liver Transplantation in Women (Video MP4 Format)

ESLD, HCC AND TRANSPLANTATION Panel Discussion Q&A (Video MP4 Format)

ESLD, HCC AND TRANSPLANTATION Update of AASLD Guidelines on Portal Hypertension (Video MP4 Format)

ESLD, HCC AND TRANSPLANTATION WILLIAM S. HAUBRICH LECTURE- Renal Dysfunction in the Cirrhotic Patient (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Alcohol Liver Disease (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Cholestatic Liver Diseases (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Colocalization of Addiction Medicine (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Emerging Therapies for Delta Hepatitis and Hepatitis B (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Management of Liver Masses (Video MP4 Format)

EVOLVING THERAPIES FOR ADVANCED LIVER CARE Panel Discussion Q&A (Video MP4 Format)

IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Diversity in MASH (Video MP4 Format)

IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Incretins for Metabolic Liver Disease (Video MP4 Format)

IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE New Nomenclature for Steatotic Liver Disease (Video MP4 Format)

IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Panel Discussion Q&A (Video MP4 Format)

IDENTIFYING AND MANAGING METABOLIC LIVER DISEASE Selective Thyroid Hormone Receptor- Beta (TRá) Agonists for MASH (Video MP4 Format)